Tapestry, Inc./Capri Holdings Limited, In the Matter of
Type of Action
Administrative
Last Updated
FTC Matter/File Number
231 0133
Docket Number
9429
Case Status
Pending
Displaying 1 - 20 of 1904
Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin)
The FTC filed a lawsuit against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
221 0114
Docket Number
9437
Case Status
Pending
FTC, DOJ Issue Fiscal Year 2023 Hart-Scott-Rodino Notification Report and Announce Corrected Fiscal Year 2022 Report
Date
The Federal Trade Commission, together with the Justice Department’s Antitrust Division, released their annual report detailing fiscal year 2023 data on the HSR Premerger Notification Program, which...
FTC Finalizes Changes to Premerger Notification Form
Date
The Federal Trade Commission voted unanimously to finalize changes to the premerger notification form and associated instructions, as well as the premerger notification rules implementing the Hart...
Federal Trade Commission and Justice Department Participate in Summit with G7 Enforcement Partners on Artificial Intelligence Competition Challenges
Date
The Federal Trade Commission and the Justice Department’s Antitrust Division participated in the G7 Competition Authorities and Policymakers Summit to discuss ways to ensure competition in artificial...
Chevron/Hess, In the Matter of
The Federal Trade Commission took action to resolve antitrust concerns related to Chevron Corporation’s acquisition of rival oil producer Hess Corporation by approving a proposed consent order that would prohibit Chevron from appointing Hess CEO John B. Hess to its Board of Directors.
The FTC’s complaint alleges that Mr. Hess communicated publicly and privately with the past and current Secretaries General of the Organization of Petroleum Exporting Countries (OPEC) and an official from Saudi Arabia. In these communications, Mr. Hess stressed the importance of oil market stability and inventory management and encouraged these officials to take actions on these issues and speak about them at different events, the complaint alleges.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
241 0008
Case Status
Pending
FTC Order Bans Hess CEO from Chevron Board in Chevron-Hess Deal
Date
The Federal Trade Commission is taking action to resolve antitrust concerns related to Chevron Corporation’s acquisition of rival oil producer Hess Corporation by approving a proposed consent order...
Statement on Memorandum of Understanding Related to Antitrust Review of Labor Issues in Merger Investigations
Date
The Federal Trade Commission has notified the other parties that it will withdraw from a Memorandum of Understanding with federal labor agencies related to merger investigations. The agency will...
FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices
Date
Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group...
Displaying 1 - 20 of 1904